Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 14, 2015; 21(26): 8140-8147
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8140
Table 2 Characteristics of the study population grouped by the presence of hepatocellular carcinoma n (%)
VariableNo HCCHCCP value
n = 89 (67)n = 44 (33)
Age (yr)48.4 ± 11.355.2 ± 8.60.00071
Gender
Male69 (78)37 (84)0.38
Female20 (22)7 (16)
Pretransplant HBsAg
Negative4 (5)2 (5)1.00
Positive84 (95)42 (95)
Pretransplant HBeAg
Negative69 (82)33 (79)0.63
Positive15 (18)15 (21)
Pretransplant HBV DNA
Negative57 (72)29 (67)0.59
Positive22 (28)14 (33)
MELD score22.2 ± 6.918.0 ± 8.20.0021
Posttransplant HBsAg
Negative75 (86)39 (91)0.46
Positive12 (14)4 (9)
Posttransplant HBeAg
Negative81 (95)41 (98)0.53
Positive4 (5)1 (2)
HDV coinfection
Negative50 (68)20 (71)0.71
Positive24 (32)8 (29)